APAF1 and ovarian carcinoma: To evaluate the effect of APAF1 on paclitaxel resistance in ovarian cancer cells in vivo, we established OVCA432 cells stably expressing doxycycline-inducible APAF1 or the control vector and injected them intraperitoneally into female nude mice, followed by paclitaxel treatment.